(Q45972500)

18 December 2017

title

Clinical trial participation among patients enrolled in the Glioma Outcomes Project. (English)

1 reference

18 December 2017

author name string

Susan M Chang

1

1 reference

18 December 2017

Fred G Barker

2

1 reference

18 December 2017

Meic H Schmidt

3

1 reference

18 December 2017

Andrew E Sloan

4

1 reference

18 December 2017

Rachel Kasper

5

1 reference

18 December 2017

Leslie Phillips

6

1 reference

18 December 2017

Karen Shih

7

1 reference

18 December 2017

Subramanian Hariharan

8

1 reference

18 December 2017

Mitchel S Berger

9

1 reference

18 December 2017

language of work or name

English

0 references

publication date

1 May 2002

1 reference

18 December 2017

published in

Cancer

1 reference

18 December 2017

volume

94

1 reference

18 December 2017

issue

10

1 reference

18 December 2017

page(s)

2681-2687

1 reference

18 December 2017

Meta-analysis of radiation therapy with and without adjuvant chemotherapy for malignant gliomas in adults

cites work

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10536

Recursive partitioning analysis of prognostic factors in three Radiation Therapy Oncology Group malignant glioma trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10536

Management of ovarian cancer: referral to a multidisciplinary team matters

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10536

Participants in prospective, randomized clinical trials for resected non-small cell lung cancer have improved survival compared with nonparticipants in such trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10536

Geographical variation in cancer patient survival in Finland: chance, confounding, or effect of treatment?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10536

Treatment centre size, entry to trials, and survival in acute lymphoblastic leukaemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10536

Centralised treatment, entry to trials and survival

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10536

Volunteers or victims: patients' views of randomised cancer clinical trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10536

Attitudes toward clinical trials among patients and the public

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10536

Participation in a clinical trial: the patients' point of view

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10536

Recruiting minorities into clinical trials: toward a participant-friendly system

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10536

Practice parameters in adults with suspected or known supratentorial nonoptic pathway low-grade glioma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10536

Prospective evaluation of cancer clinical trial accrual patterns: identifying potential barriers to enrollment

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10536

Barriers to participation in randomised controlled trials: a systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10536

Recruitment for controlled clinical trials: literature summary and annotated bibliography.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10536

Recruitment experience in clinical trials: literature summary and annotated bibliography

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10536

Determinants of patient participation in clinical studies requiring informed consent: why patients enter a clinical trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10536

Clinical trials. Concerns of the patient and the public

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10536

Randomized clinical trials in oncology: understanding and attitudes predict willingness to participate.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10536

Clinicians' attitudes to clinical trials of cancer therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10536

Fundamental dilemmas of the randomized clinical trial process: results of a survey of the 1,737 Eastern Cooperative Oncology Group investigators

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10536

Cost of care for patients in cancer clinical trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10536

Incremental costs of enrolling cancer patients in clinical trials: a population-based study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10536

The impact of managed care on clinical research: a preliminary investigation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10536

Inclusion of black Americans in oncology clinical trials: the Louisiana State University Medical Center experience

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10536

Representation of African-Americans, Hispanics, and whites in National Cancer Institute cancer treatment trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10536

Clinical trial participation. Viewpoints from racial/ethnic groups

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10536

Assuring access to state-of-the-art care for U.S. minority populations: the first 2 years of the Minority-Based Community Clinical Oncology Program.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10536

Recruitment strategies in the women's health trial: feasibility study in minority populations. WHT:FSMP Investigators Group. Women's Health Trial:Feasibility Study in Minority Populations

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10536

Threats to applicability of randomised trials: exclusions and selective participation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10536

Small-cell lung cancer: patients included in clinical trials are not representative of the patient population as a whole.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10536

Representation of older patients in cancer treatment trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10536

Unjustified exclusion of elderly people from studies submitted to research ethics committee for approval: descriptive study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10536

Oncologists' reluctance to accrue patients onto clinical trials: an Illinois Cancer Center study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10536

Treatment tolerance of elderly cancer patients entered onto phase II clinical trials: an Illinois Cancer Center study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10536

Management of patients aged over 60 years with supratentorial glioma: lessons from an audit.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10536

Supratentorial malignant gliomas: risk patterns and therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10536

Outcome in elderly patients undergoing definitive surgery and radiation therapy for supratentorial glioblastoma multiforme at a tertiary care institution.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10536

A prospective study of short-course radiotherapy in poor prognosis glioblastoma multiforme.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10536

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10536

Complementary/alternative medicine use in a comprehensive cancer center and the implications for oncology

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10536

Alternative therapy use in neurologic diseases: use in brain tumor patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10536

The prevalence of complementary/alternative medicine in cancer: a systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10536

Patient participation in research in the managed care environment: key perceptions of members in an HMO

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10536

The state of research within managed care plans: 1997 survey

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10536

Information and participation preferences among cancer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10536

The recruitment of patients into clinical trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10536

Some adaptive strategies for inadequate sample acquisition in veterans administration cooperative clinical trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10536

Why are (or are not) patients given the option to enter clinical trials?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10536

Ethical aspects of clinical trials: the attitudes of the public and out-patients

21 January 2018

2 references

https://api.crossref.org/works/10.1002%2FCNCR.10536

21 January 2018

https://api.crossref.org/works/10.1002%2FCNCR.10536

inferred from DOI database lookup

7 January 2021

based on heuristic

The Collaborative Ocular Melanoma Study (COMS) randomized trial of pre-enucleation radiation of large choroidal melanoma I: characteristics of patients enrolled and not enrolled COMS report no. 9

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10536

Retinoblastoma: a study of natural history and prognosis of 268 cases

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10536

Improving accrual into cancer clinical trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10536

Inclusion of women in clinical trials--policies for population subgroups

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10536

Women in clinical trials of new drugs. A change in Food and Drug Administration policy. The Working Group on Women in Clinical Trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10536

Obstacles to implementing cancer clinical trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10536

Psychosocial aspects of participation in early anticancer drug trials. Report of a pilot study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10536

Attitudes of patients to randomised clinical trials of cancer therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10536

Cancer patient care in clinical trials sponsored by the National Cancer Institute: what does it cost?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10536

Clinical trials in cancer therapy: efforts to improve patient enrollment by community oncologists

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10536

Underrepresentation of patients 65 years of age or older in cancer-treatment trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10536

Effects of Vinorelbine on Quality of Life and Survival of Elderly Patients With Advanced Non-Small-Cell Lung Cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10536

Generalizing from clinical trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10536

Factors influencing enrollment in clinical trials for cancer treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10536

Clinical trials. Access and reimbursement

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10536

Impediments to recruitment in the Canadian National Breast Screening Study: response and resolution

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10536

An outcome study of the RTOG Cancer Control program

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10536

Participation of community hospitals in clinical trials: analysis of five years of experience in the Eastern Cooperative Oncology Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10536

Strategic physician communication and oncology clinical trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10536

Facilitating clinical trials. The expanding role of the nurse

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10536

inferred from DOI database lookup

7 January 2021

based on heuristic

Accrual of patients into a multihospital cancer clinical trial and its implications on planning future studies

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10536

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1002/CNCR.10536

1 reference

18 December 2017

1 reference

18 December 2017